163 related articles for article (PubMed ID: 18283319)
1. The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers.
Nakano J; Huang C; Liu D; Masuya D; Yokomise H; Ueno M; Haba R; Sumitomo S
Br J Cancer; 2008 Mar; 98(6):1109-17. PubMed ID: 18283319
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).
Ling X; Yang J; Tan D; Ramnath N; Younis T; Bundy BN; Slocum HK; Yang L; Zhou M; Li F
Lung Cancer; 2005 Sep; 49(3):353-61. PubMed ID: 15936846
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancer.
Nakashima N; Huang CL; Liu D; Ueno M; Yokomise H
Int J Oncol; 2010 Sep; 37(3):687-94. PubMed ID: 20664938
[TBL] [Abstract][Full Text] [Related]
4. Differential subcellular localization of functionally divergent survivin splice variants.
Mahotka C; Liebmann J; Wenzel M; Suschek CV; Schmitt M; Gabbert HE; Gerharz CD
Cell Death Differ; 2002 Dec; 9(12):1334-42. PubMed ID: 12478470
[TBL] [Abstract][Full Text] [Related]
5. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
7. Survivin-deltaEx3: a novel biomarker for diagnosis of papillary thyroid carcinoma.
Vandghanooni S; Eskandani M; Montazeri V; Halimi M; Babaei E; Feizi MA
J Cancer Res Ther; 2011; 7(3):325-30. PubMed ID: 22044815
[TBL] [Abstract][Full Text] [Related]
8. Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.
Fangusaro JR; Jiang Y; Holloway MP; Caldas H; Singh V; Boué DR; Hayes J; Altura RA
Br J Cancer; 2005 Jan; 92(2):359-65. PubMed ID: 15655550
[TBL] [Abstract][Full Text] [Related]
9. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma.
Krepela E; Dankova P; Moravcikova E; Krepelova A; Prochazka J; Cermak J; Schützner J; Zatloukal P; Benkova K
Int J Oncol; 2009 Dec; 35(6):1449-62. PubMed ID: 19885569
[TBL] [Abstract][Full Text] [Related]
12. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis.
Ulukus EC; Kargi HA; Sis B; Lebe B; Oztop I; Akkoclu A; Onen A; Sanli A
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):31-7. PubMed ID: 17536304
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer.
Vischioni B; van der Valk P; Span SW; Kruyt FA; Rodriguez JA; Giaccone G
Ann Oncol; 2004 Nov; 15(11):1654-60. PubMed ID: 15520067
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
15. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer].
Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585
[TBL] [Abstract][Full Text] [Related]
16. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA
Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
[TBL] [Abstract][Full Text] [Related]
18. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
20. High expression of survivin and its splice variants survivin ΔEx3 and survivin 2 B in oral cancers.
Mishra R; Palve V; Kannan S; Pawar S; Teni T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):497-507. PubMed ID: 26346910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
